Plasmablastic lymphoma in an immunocompetent patient

Journal of Clinical Oncology

Volumn 27, Issue 25, 2009, Pages

  Thakral, Charu ^a   Thomas, Lilian ^a   Gajra, Ajeet ^a   Hutchison, Robert E ^a   Ravizzini, Gregory C ^a   Vajpayee, Neerja ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LACTATE DEHYDROGENASE;

AGED; APOPTOSIS; B CELL LYMPHOMA; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CASE REPORT; CELL DEATH; CELL PROLIFERATION; FEMALE; HIP PAIN; HUMAN; IMMUNOCOMPROMISED PATIENT; LACTATE DEHYDROGENASE BLOOD LEVEL; OSTEOARTHRITIS; PLASMABLASTIC LYMPHOMA; PRIORITY JOURNAL; SHORT SURVEY; TUMOR BIOPSY; WOLFF PARKINSON WHITE SYNDROME; ARTICLE; BIOPSY; COMPUTER ASSISTED TOMOGRAPHY; FATALITY; IMMUNOBLASTIC LYMPHOMA; IMMUNOCOMPETENCE; IMMUNOLOGY; IMMUNOPHENOTYPING; INFARCTION; INTESTINE; ISCHEMIA; MUSCLE TUMOR; PALLIATIVE THERAPY; PATHOLOGY; PSOAS MUSCLE; RADIATION EXPOSURE; RADIATION INJURY; RADIOGRAPHY; RADIOTHERAPY; VASCULARIZATION;

AGED, 80 AND OVER; BIOPSY; FATAL OUTCOME; FEMALE; HUMANS; IMMUNOCOMPETENCE; IMMUNOPHENOTYPING; INFARCTION; INTESTINES; ISCHEMIA; LYMPHOMA, LARGE-CELL, IMMUNOBLASTIC; MUSCLE NEOPLASMS; PALLIATIVE CARE; PSOAS MUSCLES; RADIATION INJURIES; RADIOTHERAPY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 70249094637     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2009.22.2208     Document Type: Short Survey

References (11)

1. Swerdlow S, Campo E, Harris N, et al (eds): WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (ed 4). Lyon, France, IARC Press, 2008
2. Delecluse HJ, Anagnostopoulos I, Dallenbach F, et al: Plasmablastic lymphomas of the oral cavity: A new entity associated with the human immunodeficiency virus infection. Blood 89:1413-1420, 1997
3. Jaffe E, Harris N, Stein H, et al (eds): World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France, IARC Press, 2001
4. Folk GS, Abbondanzo SL, Childers EL, et al: Plasmablastic lymphoma: A clinicopathologic correlation. Ann Diagn Pathol 10:8-12, 2006
5. Chetty R, Hlatswayo N, Muc R, et al: Plasmablastic lymphoma in HIV+ patients: An expanding spectrum. Histopathology 42:605-609, 2003
6. Lin F, Zhang K, Quiery AT Jr, et al: Plasmablastic lymphoma of the cervical lymph nodes in a human immunodeficiency virus-negative patient: A case report and review of the literature. Arch Pathol Lab Med 128:581-584, 2004
7. Colomo L, Loong F, Rives S, et al: Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities. Am J Surg Pathol 28:736-747, 2004
8. Flaitz CM, Nichols CM, Walling DM, et al: Plasmablastic lymphoma: An HIV-associated entity with primary oral manifestations. Oral Oncol 38:96-102, 2002
9. Teruya-Feldstein J: Diffuse large B-cell lymphomas with plasmablastic differentiation. Curr Oncol Rep 7:357-363, 2005
10. Vega F, Chang CC, Medeiros LJ, et al: Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles. Mod Pathol 18:806-815, 2005
11. Demasi A, Magalhaes M, Furuse C, et al: Peroxiredoxin I is differentially expressed in multiple myelomas and in plasmablastic lymphomas. Oral Dis 14:741-746, 2008